Clinical Trial Update: A Clinical Study of Immunotherapy Combined With Chemotherapy and Anti-angiogenic Therapy in Operable NSCLC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating immunotherapy combined with chemotherapy and anti-angiogenic therapy for operable non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Second Xiangya Hospital of Central South University | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN